RxDoctor Payments Data
★ My doctorsLook up a doctor →

John Dalfino, MD

Neurological Surgery · Albany, NYNPI 1245490283

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $198,000 of the $240,156 with a category attached, or 82.4%. Microvention, Inc. accounts for 91.9% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2019 at $96,385 and has fallen 96.2% since, to $3,686 in 2025. Among neurological surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$240,156in general payments, 2019–2025

Across 275 payments — averaging $873.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Microvention, Inc.$221K
  • Siemens Medical Solutions USA, Inc.$9K
  • Penumbra, Inc.$4K
  • Imperative Care, Inc$2K
  • Medtronic$838
  • Qapel Medical Inc$703
  • plus $2K from 22 others
$42,123in research payments, 2019–2025

Across 2 payments — averaging $21,061 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Microvention, Inc.$42K

What the payments were for

  • Speaking & faculty fees$198,00082%
  • Travel & lodging$32,43914%
  • Food & beverage$9,7174%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Microvention, Inc.124$220,755
Siemens Medical Solutions USA, Inc.24$9,129
Penumbra, Inc.35$3,970
Imperative Care, Inc16$2,384
Medtronic(2 entities)20$838
Qapel Medical Inc1$703
Boston Scientific19$503
Cerapedics Inc.3$280
GE HealthCare5$233
Globus Medical3$158
Integra Lifesciences Corporation6$155
Intrinsic Therapeutics1$144
Viz.ai, Inc.1$124
Mizuho America, Inc.1$120
Pacira Pharmaceuticals Incorporated1$119
Surgalign Spine Technologies, Inc.1$117
Irras USA, Inc.1$87
Lemaitre Vascular, Inc.1$75
Route 92 Medical, Inc.1$70
Clearpoint Neuro, Inc.1$39
Johnson & Johnson2$36
Bard Peripheral Vascular, Inc.2$24
Stryker1$21
Zimmer Biomet1$19
Baxter Healthcare1$15
UCB, Inc.1$14
Neural Analytics, Inc.1$13
Portola Pharmaceuticals, LLC1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$240,156 in reported general payments places this provider in the 90th percentile of 446 neurological surgery providers in New York.

See all neurological surgery providers in New York →

Medicare billing

Part B allowed, 2024
$83,627
Medicare patients
211
Services billed
391

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Albany

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →